You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sclerosing Epithelioid Fibrosarcoma

Showing 1 - 25 of 207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

Recruiting
  • Soft Tissue Sarcoma
  • +9 more
  • Patient with Soft Tissue Sarcoma
  • Besancon, France
  • +13 more
Oct 11, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

Enrolling by invitation
  • Ewing Sarcoma
  • +8 more
  • Santa Monica, California
    Sarcoma Oncology Center
Feb 23, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

Recruiting
  • Ewing Sarcoma
  • +10 more
  • Los Angeles, California
  • +16 more
Jan 18, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 29, 2023

Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

Completed
  • Objective Response
  • Overall Survival
  • VIA combination treatment
  • Beijing, China
    Peking University People's Hospital
Dec 9, 2022

Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

Not yet recruiting
  • Pleural Mesothelioma
  • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
  • Rozzano, MI, Italy
  • +5 more
Nov 30, 2023

Primary Sclerosing Cholangitis Trial in Shanghai (CS0159 2mg, Placebo)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • CS0159 2mg
  • Placebo
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiao Tong University School of Medicine
Jun 7, 2023

Primary Sclerosing Cholangitis Trial (Aramchol meglumine)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • Aramchol meglumine
  • (no location specified)
Oct 17, 2023

Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) Trial in Beijing (Sirolimus for Injection (Albumin Bound))

Recruiting
  • Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
  • Sirolimus for Injection (Albumin Bound)
  • Beijing, China
    Beijing Jishuitan Hospital
Nov 23, 2022

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • (no location specified)
Oct 3, 2022

Primary Sclerosing Cholangitis Trial in Paris, Monza, Barcelona (A3907)

Recruiting
  • Primary Sclerosing Cholangitis
  • Paris, France
  • +2 more
Jan 27, 2023

Healthy Trial in Tel Aviv (Anti-human CCL24 mAb (CM-101), Placebo)

Completed
  • Healthy
  • Anti-human CCL24 monoclonal antibody (CM-101)
  • Placebo
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) Trial in Tel Aviv (CM-101,

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • +2 more
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Primary Sclerosing Cholangitis (PSC) Trial in Warsaw (S-Adenosyl-L-methionine (SAMe), Placebo)

Recruiting
  • Primary Sclerosing Cholangitis (PSC)
  • S-Adenosyl-L-methionine (SAMe)
  • Placebo
  • Warsaw, Poland
    Department of Hepatology, Transplantology and Internal Medicine,
Sep 4, 2023

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

Scleroderma, Systemic, Morphea, Graft Vs Host Disease Trial in Murray (UVA-1 Phototherapy)

Enrolling by invitation
  • Scleroderma, Systemic
  • +2 more
  • UVA-1 Phototherapy
  • Murray, Utah
    University of Utah Dermatology
Nov 1, 2022

PEComa Trial in United States (ABI-009)

Completed
  • PEComa
  • Palo Alto, California
  • +8 more
Apr 29, 2022

Histologic Prognostic Factors in Peritoneal Malignant

Recruiting
  • Peritoneal Malignant Mesothelioma
  • No intervention
  • Gent, Belgium
  • +5 more
Dec 31, 2021

Perivascular Epithelioid Cell Tumors

Recruiting
  • Perivascular Epithelioid Cell Tumor, Malignant
    • Strasbourg, France
      Service d'Oncologie - CHU de Strasbourg - France
    Nov 7, 2022

    Biliary Cell-derived Organoids From Bile of PSC and Non-PSC

    Recruiting
    • Primary Sclerosing Cholangitis
    • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 9, 2023

      Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

      Suspended
      • Solid Tumor
      • ARID1A Gene Mutation
      • Greenville, South Carolina
        Prisma Health Cancer Institute
      Jan 10, 2023

      Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

      Recruiting
      • Angiosarcoma
      • Epithelioid Hemangioendothelioma
      • Boston, Massachusetts
      • +1 more
      Feb 14, 2022

      Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

      Active, not recruiting
      • Malignant Rhabdoid Tumors (MRT)
      • +10 more
      • San Francisco, California
      • +31 more
      Jan 17, 2023